Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
We report on a patient suffering from seizures caused by cerebral metastases of adenocarcinoma of the lung. Initially, the patient was treated effectively with oral levetiracetam. As the disease progressed, oral intake was no longer possible. Since levetiracetam had controlled the patient's sei...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Mary Ann Liebert
2021-05-01
|
| Series: | Palliative Medicine Reports |
| Online Access: | https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0119 |